Literature DB >> 16341805

Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like families.

Shiri Dovrat1, Arie Figer, Herma H Fidder, Pavlos Neophytou, Zvi Fireman, Ravit Geva, Jamal Zidan, Dov Flex, Shimon Bar Meir, Eitan Friedman.   

Abstract

Germline mutations in DNA mismatch repair (DNA-MMR) genes, mainly hMlh1 and hMsh2, underlie Hereditary Non-Polyposis Colorectal Cancer (HNPCC). Germline hMSH6 gene mutations have been reported in a small subset of HNPCC families. In the present study, ethnically diverse individuals with HNPCC and HNPCC-like features were genotyped for hMsh6 germline mutations using exon-specific PCR, DGGE, and DNA sequencing. The study encompassed 92 individuals representing 88 unrelated families who were previously analyzed for Msh2 and Mlh1 mutations: Jewish Ashkenazim (n = 44), non-Ashkenazim (n = 27), Israeli Moslem-Arab (n = 15), Druze (n=3), and Cypriot non-Jews (n = 3). Of the study population, 71 had colon cancer (CRC), mean age at diagnosis was 50.9+/-13.2 years (range 16-73 years), 5 had endometrial cancer (two with concurrent CRC), (mean 43.6+/-3.26 years, range 38-45 years), and unaffected individuals (n = 18) were first degree relatives within HNPCC families and were genotyped at a mean age of 48.3+/-11.7 years (range 30-69 years). Of the 92 individuals analyzed, none showed a truncating hMsh6 mutation, and 6 (6.6%) harbored one of three germline missense mutations: a previously reported one (V878A), and two novel mutations (V509A, S227I). The pathogenic significance of these three missense mutations is yet unclear. In addition, 5 polymorphisms were detected, 2 of which were novel. We conclude that the rate of pathogenic hMsh6 mutations in HNPCC families of Jewish and Mediterranean origin is low, and that mutations in other genes probably account for the phenotype in these families.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16341805     DOI: 10.1007/s10689-005-1255-7

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  28 in total

Review 1.  Do MSH6 mutations contribute to double primary cancers of the colorectum and endometrium?

Authors:  G S Charames; A L Millar; T Pal; S Narod; B Bapat
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

2.  MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer.

Authors:  J Huang; S A Kuismanen; T Liu; R B Chadwick; C K Johnson; M W Stevens; S K Richards; J E Meek; X Gao; F A Wright; J P Mecklin; H J Järvinen; H Grönberg; M L Bisgaard; A Lindblom; P Peltomäki
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

3.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.

Authors:  Y Akiyama; H Sato; T Yamada; H Nagasaki; A Tsuchiya; R Abe; Y Yuasa
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

4.  The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas.

Authors:  J M Cunningham; C Y Kim; E R Christensen; D J Tester; Y Parc; L J Burgart; K C Halling; S K McDonnell; D J Schaid; C Walsh Vockley; V Kubly; H Nelson; V V Michels; S N Thibodeau
Journal:  Am J Hum Genet       Date:  2001-08-24       Impact factor: 11.025

5.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.

Authors:  Q Wang; C Lasset; F Desseigne; J C Saurin; C Maugard; C Navarro; E Ruano; L Descos; V Trillet-Lenoir; J F Bosset; A Puisieux
Journal:  Hum Genet       Date:  1999 Jul-Aug       Impact factor: 4.132

7.  Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers.

Authors:  L D Kowalski; D G Mutch; T J Herzog; J S Rader; P J Goodfellow
Journal:  Genes Chromosomes Cancer       Date:  1997-03       Impact factor: 5.006

8.  Clues to the pathogenesis of familial colorectal cancer.

Authors:  L A Aaltonen; P Peltomäki; F S Leach; P Sistonen; L Pylkkänen; J P Mecklin; H Järvinen; S M Powell; J Jen; S R Hamilton
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

9.  Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer.

Authors:  E Lucci-Cordisco; V Rovella; S Carrara; A Percesepe; M Pedroni; A Bellacosa; O Caluseriu; M Forasarig; M Anti; G Neri; M Ponz de Leon; A Viel; M Genuardi
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

10.  Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.

Authors:  P Peltomäki; R A Lothe; L A Aaltonen; L Pylkkänen; M Nyström-Lahti; R Seruca; L David; R Holm; D Ryberg; A Haugen
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

View more
  3 in total

Review 1.  Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities.

Authors:  Michael A Edelbrock; Saravanan Kaliyaperumal; Kandace J Williams
Journal:  Mutat Res       Date:  2013-02-04       Impact factor: 2.433

2.  Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.

Authors:  Gasper Berginc; Matej Bracko; Metka Ravnik-Glavac; Damjan Glavac
Journal:  Fam Cancer       Date:  2009-06-13       Impact factor: 2.375

3.  Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity.

Authors:  Hellen Houlleberghs; Anne Goverde; Jarnick Lusseveld; Marleen Dekker; Marco J Bruno; Fred H Menko; Arjen R Mensenkamp; Manon C W Spaander; Anja Wagner; Robert M W Hofstra; Hein Te Riele
Journal:  PLoS Genet       Date:  2017-05-22       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.